← Back to headlines
Tarsus Pharma Stock Rises 20% Amid Insider RSU Sale
Tarsus Pharma's stock saw a 20% increase following an insider's sale of $839,000 in RSU-linked trades.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
